Form 4: Palantir Director Sells Shares Under Pre-Arranged Trading Plan
SEC Form 4 Filing
A Palantir Technologies director, Lauren Elaina Friedman, and her spouse sold shares of Class A Common Stock under pre-arranged 10b5-1 trading plans.
Summary
- Lauren Elaina Friedman, a director at Palantir Technologies, sold 800 shares of Class A Common Stock at $76.29 per share on January 2, 2025.
- These shares were sold directly by Ms. Friedman.
- Ms. Friedman's spouse also sold 1,000 shares of Class A Common Stock at $76.29 per share on the same day.
- These shares were sold indirectly by Ms. Friedman through her spouse.
- Both sales were executed under pre-arranged Rule 10b5-1 trading plans.
- Ms. Friedman's plan was established on September 12, 2024, and her spouse's plan was established on September 11, 2024.
Sentiment
Score: 5
Explanation: The document is neutral as it reports routine insider sales under a pre-arranged plan. There is no indication of positive or negative sentiment.
Risks
- Sales by insiders can sometimes be perceived negatively by the market, potentially impacting the stock price.
Industry Context
Insider sales are a common occurrence in publicly traded companies, and the use of 10b5-1 plans is a standard practice to avoid accusations of trading on non-public information. This filing is a routine disclosure.
Comparison to Industry Standards
- The use of 10b5-1 trading plans is a common practice among executives and directors at publicly traded companies, including technology companies like Palantir.
- Similar filings are regularly seen from directors and officers at companies like Microsoft, Google, and Amazon, where pre-planned sales are often executed to manage personal finances and avoid insider trading concerns.
- The volume of shares sold is relatively small compared to the overall trading volume of Palantir stock, suggesting this is a routine transaction rather than a significant shift in insider sentiment.
Stakeholder Impact
- The sales may have a minor impact on shareholder sentiment, but the pre-planned nature of the transactions mitigates any significant concern.
Key Dates
| Date | Description |
|---|---|
| 2024-09-11 | Date the spouse's Rule 10b5-1 trading plan was entered into. |
| 2024-09-12 | Date the director's Rule 10b5-1 trading plan was entered into. |
| 2025-01-02 | Date of the stock sales by the director and her spouse. |
| 2025-01-06 | Date the Form 4 was signed. |
Keywords
Palantir, insider trading, Form 4, Rule 10b5-1, stock sale, Lauren Elaina Friedman, director
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.